| Alexandria Monique Landaverde, PHARM D | |
|
1620 N Whitley Dr, Fruitland, ID 83619-2129 | |
| (208) 452-7075 | |
| Not Available |
| Full Name | Alexandria Monique Landaverde |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 1620 N Whitley Dr, Fruitland, Idaho |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205409158 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | P9427 (Idaho) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Alexandria Monique Landaverde, PHARM D 781 S Thornwood Way, Meridian, ID 83642-3530 Ph: (541) 212-9027 | Alexandria Monique Landaverde, PHARM D 1620 N Whitley Dr, Fruitland, ID 83619-2129 Ph: (208) 452-7075 |
News Archive
A team from IDIBELL and ICO, using a mouse orthotopic model, conducted a real-time personalized oncology study to test the best therapeutic option to treat a type of relapse sarcoma. Malignant Peripheral Nerve Sheath Tumor are very aggressive and do not usually have a good prognosis, especially if complete surgical excision cannot be achieved.
A research team led by the La Jolla Institute for Allergy & Immunology has identified the specific gene which triggers the body to produce disease-fighting antibodies - a seminal finding that clarifies the exact molecular steps taken by the body to mount an antibody defense against viruses and other pathogens.
A drug approved by the Food and Drug Administration for melanoma in combination with a common cholesterol-lowering drug may show promise in controlling cancer growth in patients with non-small cell lung cancer (NSCLC), according to new research from the Icahn School of Medicine at Mount Sinai.
Verastem, Inc., operating as Verastem Oncology, a biopharmaceutical company focused on developing and commercializing medicines to improve the survival and quality of life of cancer patients, today announced dosing of the first patient in a multicenter Phase I/II clinical trial at the Dana-Farber/Harvard Cancer Center of duvelisib in combination with venetoclax in patients with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma.
Valeant Pharmaceuticals International, Inc. announced that its wholly owned subsidiary, Valeant International (Barbados) SRL, has received notice that the New Drug Submission for colesevelam hydrochloride (colesevelam), an oral bile acid sequestrant for hypercholesterolemia, has been approved by the Canadian regulatory authority Health Canada.
› Verified 8 days ago
Judd Alan Knudsen, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1620 N Whitley Dr, Fruitland, ID 83619 Phone: 208-452-7075 Fax: 208-452-7446 | |
Janette Kameshige, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1620 N Whitley Dr, Fruitland, ID 83619 Phone: 208-452-7075 | |
Joseph Weatherspoon, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1210 Nw 16th St, Fruitland, ID 83619 Phone: 208-452-8700 Fax: 208-452-8701 | |
Dr. Ryan Charles Zimmerly, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1118 Nw 16th St, Suite D., Fruitland, ID 83619 Phone: 208-452-8698 | |
Mrs. Erin Doraine Jackson, PHARMD, CDM Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1620 N Whitley Dr, Fruitland, ID 83619 Phone: 208-452-7075 Fax: 208-452-7446 | |
Adam Robert Kramer, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1118 Nw 16th St Ste D, Fruitland, ID 83619 Phone: 208-452-8698 |